Type 2 diabetes and cardiovascular disease are directly linked -- but not because of blood sugar.  Metabolic disorders play the major role in increasing heart disease risk in diabetic patients. 

Miami Cardiac & Vascular Institute's cardiometabolic and prevention center is taking a comprehensive approach to these patients, aimed at controlling blood pressure, cholesterol, triglycerides, obesity and other factors.  Medications can play a role that goes beyond treating symptoms to actually helping prevent negative cardiac events.

Host, Jonathan Fialkow, M.D., a preventative cardiologist at Miami Cardiac & Vascular Institute, welcomes  guests Lisa Davis, PA, a clinical lipid specialist, and clinical pharmacist Jennifer Miles, PharmD., for a discussion about using medications to reduce diabetic cardiac risk.